Risk factors and postoperative complications following revision total knee arthroplasty in patients with metabolic syndrome–associated osteoarthritis: a 10-year retrospective analysis using a national inpatient database - Report - MDSpire
Advertisement
Postoperative Outcomes and Risk Factors in Revision Total Knee Arthroplasty for Patients with Osteoarthritis Linked to Metabolic Syndrome: A Decade-Long Retrospective Study Utilizing a National Inpatient Database
Clinical Report: Postoperative Outcomes in Revision Total Knee Arthroplasty
Overview
This study examines the increasing prevalence of metabolic syndrome-associated osteoarthritis (MetS-OA) among patients undergoing revision total knee arthroplasty (RTKA) and identifies associated risk factors.
Background
Osteoarthritis (OA) is a prevalent degenerative joint disorder, particularly among older adults. Metabolic syndrome-associated osteoarthritis (MetS-OA) has emerged as a significant clinical phenotype, with its prevalence rising in parallel with the aging population and increasing obesity rates.
Data Highlights
Metric
Value
Prevalence of MetS-OA
16.1%
Increased hospitalization charges
$1,445.50
Postoperative complications
Higher likelihood compared to non-MetS-OA
Key Findings
The prevalence of MetS-OA among RTKA patients increased from 2011 to 2019.
Independent risk factors for MetS-OA include advanced age, male sex, non-White racial background, and comorbid conditions.
Patients with MetS-OA had longer hospital stays and higher hospitalization charges.
In-hospital mortality rates were similar between patients with and without MetS-OA.
MetS-OA was associated with a higher incidence of postoperative complications.
Clinical Implications
Healthcare providers should be aware of the increasing prevalence of MetS-OA and its associated risks when planning for RTKA.
Conclusion
The study highlights the growing impact of MetS-OA on RTKA outcomes.
